Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone replacement therapy and cardiovascular assessment in girls with Turner syndrome
2004-004778-99Phase 4Completed
- Sponsor
- Nordsjællands Hospital
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of estradiol, ethinylestradiol + levonorgestrel and norethisterone acetate in Turner syndrome (TS) and Hypogonadism, sponsored by Nordsjællands Hospital. Primary endpoint: Uterine size by magnetic resonance imaging. Started May 2005; status: completed.
02
Drugs
estradiolethinylestradiol + levonorgestrelnorethisterone acetate
03
Conditions
Turner syndrome (TS)Hypogonadism
Beyond the preview
Go deeper on 2004-004778-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004778-99.